The economic benefits of the SaniGuard Isolation Pod

 

Introduction

SaniGuard is a cleanroom style isolation pod for use in hospitals and care facilities to treat patients that are infected with communicable diseases, such as coronavirus.

It's essentially a high-tech "tent" that delivers sterile air to the infectious patient while simultaneously creating a barrier between patient and the rest of the room.

The key aspect of SaniGuard is the constant supply and removal air in a manner that maintains a negative pressure within the tent. The negative pressure ensures that air contaminated with infectious pathogens cannot escape, especially when care, medication or nutrition is given to the patient.

The entire volume of air within the pod is complete replaced every four (4) minutes. This means the concentration of air borne infectious pathogens (exhaled from the patient) is constantly kept at the very low level. Thus dramatically reducing re-inhalation of harmful, active pathogens.

All the air that is removed is irradiated with UV "C" spectrum light to kill the microbes carried in the air and exhaled aerosol. Before exiting the pod, the disinfected air is further filtered though an ULPA filter. This is a class of filter better the HEPA filters and has a collection efficiency of 99.999% for particles as small as 0.1 microns. Collectively, this air cleaner ensures the absolute highest level of safety.

The air entering the pod is cleaned in exactly the same way. This ensures optimum air conditions for the patient. The combined effect of sterile air and rapid removal of the active pathogens exhaled by the patient assists in reducing the patient's recovery time.

Health Benefits

    The benefits of SaniBot can therefore be summarized as follows;
  • Faster recovery times. The sooner the patient is placed into the pod after symptoms show, the better the recovery time.
  • Far superior protection for healthcare workers and support staff. The design and engineering measures will allow a guarantee of zero transmission from the patient to their caregiver. The fewer caregiver infected the lower community transmission will be, and particularly transmissions to vulnerable members in the community.

Economic Benefits

Based on 2018 figures, the national average cost per admitted acute overnight hospital stay is $2,074 plus the cost of diagnostic procedures and medication.

The median length of time a patient infected with coronavirus stays in hospital is 10 to 13 days. Meaning that the indicative cost is at least $23,800 per recovered patient.

It's anticipated that patients isolated in a SaniGuard could have a 25% shorter recovery time. This represents an indicative saving of $5,900 per recovered patient.

Currently 13% of active coronavirus cases are healthcare workers that were infected by 29% of infected persons in aged-care facilities and hospitals. 42% of infected healthcare workers are nurses, mostly working within hospitals.

The all-in costs of a healthcare worker on $35/hr generally produces an opex of about $500 per day. Therefore, if a healthcare worker becomes infected and furloughed for a minimum period of 14 days, it costs the hospital $14,000.

Meaning the overall cost benefit of a SaniGuard if it reduced one patient's hospitalisation and prevented just one healthcare worker from acquiring the virus, is therefore $19,900 per fortnight or $517,000 annually.

Since the cost of a SaniGuard is less than $30,000 (including annual maintenance), its return on investment is greater than 1,700%.


For SaniGuard's technical details, please refer to the SaniGuard Product Page

Close

Contact Us

Thanks for your interest in SaniBot. It will be our pleasure to assist you further.

info@sanibot.com.au

(03)8317 4551

Subscribe error, please review your email address.

Close

You're now subscribed, thank you!

Close

There was a problem with your submission. Please check the field(s) with red label below.

Close

Your message has been sent. We'll get back to you soon!

Close